Vikas Lifecare Limited has informed the Exchange regarding Board meeting held on August 14, 2025.
VIKASLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Vikas Lifecare approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). On a standalone basis, revenue from operations fell to ₹8,869.19 lakhs from ₹9,156.18 lakhs in Q1 FY25, and the company swung to a loss before tax of ₹(277.36) lakhs compared to a small profit of ₹87.72 lakhs a year ago, posting a net loss of ₹(280.03) lakhs. On a consolidated basis, revenue rose marginally to ₹9,238.36 lakhs, but the net loss widened to ₹(395.27) lakhs (from ₹(291.57) lakhs), including a ₹124.45 lakhs share of loss from an associate company. The board also accepted the resignation of Independent Director Ms. Samanta Yadav for personal reasons and appointed CA Vijay Kumar Goel as a new Non-Executive Independent Director, subject to shareholder approval. The Nomination and Remuneration Committee was reconstituted accordingly.
The Q1 results are weak — the standalone business slipped back into a loss despite stable revenues, and the consolidated loss deepened due to associate-level losses, which is mildly negative for shareholders. The director change is routine, but the appointment of a chartered accountant with banking and project-finance experience could be viewed positively from a governance standpoint.